From SNPedia
rs2981582, a SNP associated with the
FGFR2 gene, was one of the four strongest associating SNPs found in a genome-wide association study of over 4,000
breast cancer samples.[
PMID 17529967]
[PMID 18437204] breast cancer
- rs2981582 in FGFR2 was more strongly related to ER-positive (per-allele odds ratio 1.31 (CI: 1.27-1.36)) than ER-negative (odds ratio 1.08 (CI:1.03-1.14)) disease (p for heterogeneity = 10(-13)).
[PMID 18579814] breast cancer
- rs2981582, while on it's own still of fairly small effect, was the most significant (other than from family history and/or BRCA1 or BRCA2 testing) of the SNPs chosen in a 7 SNP panel to help estimate risk of breast cancer
[PMID 18845558] breast cancer
- Based on a study of 1,049 Chinese breast cancer patients, carriers of risk alleles at three SNPs (rs2981582, rs1219648 and rs2420946) were at 1.36x increased risk for breast cancer (CI: 1.13-1.62, p = 0.001).
[PMID 18973230] A study of 1,173 Caucasian ovarian cancer patients did not find strong support for an association with rs2981582.
[PMID 19005751] rs2981582 confirmed in 988 sporadic breast cancer cases and 1,016 controls from the West of Ireland to be associated with increased risk (odds ratio 1.22, p(allelic) = 2.2 x 10e-3) for breast cancer
[PMID 19028704] A study of 1,225 Caucasian breast cancer patients found a significant association between rs2981582 but only in women with estrogen receptor positive (ER+), progesterone receptor positive (PR+) and HER2/Neu negative (HER2-) tumors.
| ? | (C;C) (C;T) (T;T) |
 |
| GWAS
|
| SNP
| rs2981582
|
| PubMedID
| [PMID 17529967]
|
| Condition
| Breast cancer
|
| Gene
| FGFR2
|
| Risk Allele
| G
|
| pValue
| 2.00E-076
|
| OR
| 1.26
|
| 95% CI
| 1.23-1.30
|
[PMID 19536173] Association of FGFR2 gene polymorphisms with the risk of breast cancer in population of West Siberia
Related to FIBROBLAST GROWTH FACTOR RECEPTOR 2; FGFR2
according to
omim 176943. See
also
| PharmGKB | PA161615666 |
| Name | |
| Annotation | The minor allele of this SNP has been associated with increased risk of breast cancer in BRCA2 mutation carriers. |
| Gene | FGFR2 |
| Featue | |
| Evidence | PubMed ID:18355772 |
| Drugs | |
| Diseases | Breast Neoplasms |
| Curation Level | Curated |